Related Experiment Video
Updated: Sep 22, 2025

Author Spotlight: Evaluation of Protein-Condensate Dynamics in Live Human Cells
Published on: January 5, 2024
Convergent Alterations of a Protein Hub Produce Divergent Effects within a Binding Site
Ali Imran1, Brandon S Moyer2, Dan Kalina2,3
1Department of Physics, Syracuse University, 201 Physics Building, Syracuse, New York 13244-1130, United States.
Abstract:
Progress in tumor sequencing and cancer databases has created an enormous amount of information that scientists struggle to sift through. While several research groups have created computational methods to analyze these databases, much work still remains in distinguishing key implications of pathogenic mutations. Here, we describe an approach to identify and evaluate somatic cancer mutations of WD40 repeat protein 5 (WDR5), a chromatin-associated protein hub. This multitasking protein maintains the functional integrity of large multi-subunit enzymatic complexes of the six human SET1 methyltransferases. Remarkably, the somatic cancer mutations of WDR5 preferentially distribute within and around an essential cavity, which hosts the WDR5 interaction (Win) binding site. Hence, we assessed the real-time binding kinetics of the interactions of key clustered WDR5 mutants with the Win motif peptide ligands of the SET1 family members (SET1Win). Our measurements highlight that this subset of mutants exhibits divergent perturbations in the kinetics and strength of interactions not only relative to those of the native WDR5 but also among various SET1Win ligands. These outcomes could form a fundamental basis for future drug discovery and other developments in medical biotechnology.
Insights
Researchers analyzed cancer mutations in WDR5 (WD40 repeat protein 5), a key protein hub. They found mutations alter WDR5
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Tumor sequencing generates vast data, necessitating methods to interpret pathogenic mutations.
- WD40 repeat protein 5 (WDR5) is a chromatin-associated protein hub crucial for SET1 methyltransferase complexes.
Purpose of the Study:
- To identify and evaluate somatic cancer mutations in WDR5.
- To assess the impact of WDR5 mutations on its interaction kinetics with SET1 methyltransferases.
Main Methods:
- Computational analysis of cancer mutation databases.
- Real-time binding kinetics assays using WDR5 mutants and SET1Win peptides.
Main Results:
- Somatic WDR5 mutations cluster around a critical binding cavity.
- Mutated WDR5 shows altered binding kinetics and affinity for SET1Win ligands.
Conclusions:
- WDR5 mutations differentially affect interactions with SET1 family members.
- Findings provide a basis for WDR5-targeted drug discovery in cancer biotechnology.
More Related Videos
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Ligand Binding and Linkage
Cooperative Allosteric Transitions
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-protein Interfaces
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...

